Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Amylin as a potential link between type 2 diabetes and alzheimer disease.

Martinez-Valbuena I, Valenti-Azcarate R, Amat-Villegas I, Riverol M, Marcilla I, de Andrea CE, Sánchez-Arias JA, Del Mar Carmona-Abellan M, Marti G, Erro ME, Martínez-Vila E, Tuñon MT, Luquin MR.

Ann Neurol. 2019 Oct;86(4):539-551. doi: 10.1002/ana.25570. Epub 2019 Aug 19.

PMID:
31376172
2.

Cardiac sympathetic innervation in the MPTP non-human primate model of Parkinson disease.

Carmona-Abellan M, Martínez-Valbuena I, DiCaudo C, Marcilla I, Luquin MR.

Clin Auton Res. 2019 Aug;29(4):415-425. doi: 10.1007/s10286-019-00620-0. Epub 2019 Jul 23.

PMID:
31338635
3.

Globular glial tauopathy caused by MAPT P301T mutation: clinical and neuropathological findings.

Erro ME, Zelaya MV, Mendioroz M, Larumbe R, Ortega-Cubero S, Lanciego JL, Lladó A, Cabada T, Tuñón T, García-Bragado F, Luquin MR, Pastor P, Ferrer I.

J Neurol. 2019 Oct;266(10):2396-2405. doi: 10.1007/s00415-019-09414-w. Epub 2019 Jun 12.

PMID:
31190169
4.

Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers.

Carmona-Abellan M, Gabilondo I, Murueta-Goyena A, Khurana V, Tijero B, Luquin MR, Acera M, Del Pino R, Gardeazabal J, Martínez-Valbuena I, Sanchez-Pernaute R, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2019 Aug;65:139-145. doi: 10.1016/j.parkreldis.2019.05.038. Epub 2019 Jun 5.

PMID:
31178336
5.

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson's Disease.

Lasbleiz C, Mestre-Francés N, Devau G, Luquin MR, Tenenbaum L, Kremer EJ, Verdier JM.

Front Mol Neurosci. 2019 Feb 11;12:10. doi: 10.3389/fnmol.2019.00010. eCollection 2019.

6.

Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice.

Noguera-Ortega E, Rabanal RM, Gómez-Mora E, Cabrera C, Luquin M, Julián E.

Sci Rep. 2018 Oct 10;8(1):15102. doi: 10.1038/s41598-018-33253-w.

7.

Validation of a simple screening tool for early diagnosis of advanced Parkinson's disease in daily practice: the CDEPA questionnaire.

Martinez-Martin P, Kulisevsky J, Mir P, Tolosa E, García-Delgado P, Luquin MR.

NPJ Parkinsons Dis. 2018 Jul 2;4:20. doi: 10.1038/s41531-018-0056-2. eCollection 2018.

8.

The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia.

Rojo-Bustamante E, Abellanas MA, Clavero P, Thiolat ML, Li Q, Luquin MR, Bezard E, Aymerich MS.

Neurobiol Dis. 2018 Oct;118:64-75. doi: 10.1016/j.nbd.2018.06.019. Epub 2018 Jun 21.

PMID:
29936234
9.

Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.

Martinez-Valbuena I, Amat-Villegas I, Valenti-Azcarate R, Carmona-Abellan MDM, Marcilla I, Tuñon MT, Luquin MR.

Acta Neuropathol. 2018 Jun;135(6):877-886. doi: 10.1007/s00401-018-1832-0. Epub 2018 Mar 13.

PMID:
29536165
10.

[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].

Garcia-Ruiz PJ, Sanz-Cartagena P, Martinez-Castrillo JC, Ares-Pensado B, Aviles-Olmos I, Blazquez-Estrada M, Fanjul-Arbos S, Garcia-Caldentey J, Gazulla J, Gutierrez-Garcia J, Huete-Anton B, Lucas-Rodenas C, Luquin MR, Martinez-Torres I, Medialdea-Natera P, Mendoza-Rodriguez A, Mir-Rivera P, Posada IJ, Ruiz-Martinez J, Sanchez-Alonso P, Trejo-Gabriel Y Galan JM, Vela L, Pena-Segura JL.

Rev Neurol. 2018 Mar 1;66(5):163-172. Review. Spanish.

11.

Molecule confirmation and structure characterization of pentatriacontatrienyl mycolate in Mycobacterium smegmatis.

Llorens-Fons M, Julián E, Luquin M, Pérez-Trujillo M.

Chem Phys Lipids. 2018 May;212:138-143. doi: 10.1016/j.chemphyslip.2017.12.006. Epub 2017 Dec 30.

PMID:
29291384
12.

Trehalose Polyphleates, External Cell Wall Lipids in Mycobacterium abscessus, Are Associated with the Formation of Clumps with Cording Morphology, Which Have Been Associated with Virulence.

Llorens-Fons M, Pérez-Trujillo M, Julián E, Brambilla C, Alcaide F, Byrd TF, Luquin M.

Front Microbiol. 2017 Jul 25;8:1402. doi: 10.3389/fmicb.2017.01402. eCollection 2017.

13.

Isolated palatal tremor as unique clinical manifestation of SCA 18 due to a new mutation of IFRD1.

Echeveste B, Covarrubias E, Cabello JP, Luquin MR.

Parkinsonism Relat Disord. 2017 Sep;42:100-101. doi: 10.1016/j.parkreldis.2017.05.026. Epub 2017 May 31. No abstract available.

PMID:
28601596
14.

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study).

Luquin MR, Kulisevsky J, Martinez-Martin P, Mir P, Tolosa ES.

Parkinsons Dis. 2017;2017:4047392. doi: 10.1155/2017/4047392. Epub 2017 Jan 23.

15.

Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein.

Rodríguez-Nogales C, Garbayo E, Martínez-Valbuena I, Sebastián V, Luquin MR, Blanco-Prieto MJ.

Int J Pharm. 2016 Nov 30;514(1):142-149. doi: 10.1016/j.ijpharm.2016.06.044.

PMID:
27863657
16.

Mycobacteria Clumping Increase Their Capacity to Damage Macrophages.

Brambilla C, Llorens-Fons M, Julián E, Noguera-Ortega E, Tomàs-Martínez C, Pérez-Trujillo M, Byrd TF, Alcaide F, Luquin M.

Front Microbiol. 2016 Oct 4;7:1562. eCollection 2016.

17.

Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys.

Garbayo E, Ansorena E, Lana H, Carmona-Abellan MD, Marcilla I, Lanciego JL, Luquin MR, Blanco-Prieto MJ.

Biomaterials. 2016 Dec;110:11-23. doi: 10.1016/j.biomaterials.2016.09.015. Epub 2016 Sep 21.

PMID:
27697668
18.

Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.

Noguera-Ortega E, Blanco-Cabra N, Rabanal RM, Sánchez-Chardi A, Roldán M, Guallar-Garrido S, Torrents E, Luquin M, Julián E.

Sci Rep. 2016 Jun 6;6:27232. doi: 10.1038/srep27232.

19.

Magneto-actuated immunoassay for the detection of Mycobacterium fortuitum in hemodialysis water.

Brugnera MF, Bundalian R Jr, Laube T, Julián E, Luquin M, Zanoni MV, Pividori MI.

Talanta. 2016 Jun 1;153:38-44. doi: 10.1016/j.talanta.2016.02.041. Epub 2016 Feb 18.

PMID:
27130087
20.

Draft Genome Sequence of Mycobacterium brumae ATCC 51384.

D'Auria G, Torrents E, Luquin M, Comas I, Julián E.

Genome Announc. 2016 Apr 28;4(2). pii: e00237-16. doi: 10.1128/genomeA.00237-16.

21.

Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo.

Noguera-Ortega E, Secanella-Fandos S, Eraña H, Gasión J, Rabanal RM, Luquin M, Torrents E, Julián E.

Eur Urol Focus. 2016 Apr;2(1):67-76. doi: 10.1016/j.euf.2015.03.003. Epub 2015 Jun 6.

PMID:
28723453
22.

Brain aging and Parkinson's disease: New therapeutic approaches using drug delivery systems.

Rodríguez-Nogales C, Garbayo E, Carmona-Abellán MM, Luquin MR, Blanco-Prieto MJ.

Maturitas. 2016 Feb;84:25-31. doi: 10.1016/j.maturitas.2015.11.009. Epub 2015 Nov 21. Review.

23.

Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.

Zelaya MV, Pérez-Valderrama E, de Morentin XM, Tuñon T, Ferrer I, Luquin MR, Fernandez-Irigoyen J, Santamaría E.

Oncotarget. 2015 Nov 24;6(37):39437-56. doi: 10.18632/oncotarget.6254.

24.

γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria.

Noguera-Ortega E, Rabanal RM, Secanella-Fandos S, Torrents E, Luquin M, Julián E.

J Urol. 2016 Jan;195(1):198-205. doi: 10.1016/j.juro.2015.07.011. Epub 2015 Jul 10.

PMID:
26165584
25.

Metabolic patterns in prion diseases: an FDG PET voxel-based analysis.

Prieto E, Domínguez-Prado I, Riverol M, Ortega-Cubero S, Ribelles MJ, Luquin MR, de Castro P, Arbizu J.

Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1522-9. doi: 10.1007/s00259-015-3090-x. Epub 2015 Jun 4.

PMID:
26041084
26.

[Neuropsychological profile of frontotemporal lobar degeneration].

Carmona-Abellán MM, Luquin MR, Lamet I, Pujol Giménez N, Esteve-Belloch P, Rivero M.

An Sist Sanit Navar. 2015 Jan-Apr;38(1):79-92. Review. Spanish.

27.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Tijero B, Gabilondo I, Lezcano E, Teran-Villagrá N, Llorens V, Ruiz-Martinez J, Marti-Masso JF, Carmona M, Luquin MR, Berganzo K, Fernandez I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 Jul;21(7):717-22. doi: 10.1016/j.parkreldis.2015.04.012. Epub 2015 Apr 23.

PMID:
25960264
28.

Primary Whipple disease of the CNS presenting with chorea and dystonia: A video case report.

Palma JA, Luquin MR, Riverol M, Irimia P, Fernandez-Alonso M, Tejada J, Martinez-Vila E.

Neurol Clin Pract. 2014 Dec;4(6):508-510. doi: 10.1212/CPJ.0000000000000055. No abstract available.

29.

[Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].

Arbizu J, Luquin MR, Abella J, de la Fuente-Fernández R, Fernandez-Torrón R, García-Solís D, Garrastachu P, Jiménez-Hoyuela JM, Llaneza M, Lomeña F, Lorenzo-Bosquet C, Martí MJ, Martinez-Castrillo JC, Mir P, Mitjavila M, Ruiz-Martínez J, Vela L.

Rev Esp Med Nucl Imagen Mol. 2014 Jul-Aug;33(4):215-26. doi: 10.1016/j.remn.2014.02.001. Epub 2014 Apr 14. Review. Spanish.

PMID:
24731551
30.

Sustained increase of PKA activity in the postcommissural putamen of dyskinetic monkeys.

Azkona G, Marcilla I, López de Maturana R, Sousa A, Pérez-Navarro E, Luquin MR, Sanchez-Pernaute R.

Mol Neurobiol. 2014 Dec;50(3):1131-41. doi: 10.1007/s12035-014-8688-7. Epub 2014 Apr 5.

PMID:
24705818
31.

The adult macaque spinal cord central canal zone contains proliferative cells and closely resembles the human.

Alfaro-Cervello C, Cebrian-Silla A, Soriano-Navarro M, Garcia-Tarraga P, Matías-Guiu J, Gomez-Pinedo U, Molina Aguilar P, Alvarez-Buylla A, Luquin MR, Garcia-Verdugo JM.

J Comp Neurol. 2014 Jun 1;522(8):1800-17. doi: 10.1002/cne.23501.

PMID:
24638933
32.

[Predictive factors of the response to treatment with onabotulinumtoxinA in refractory migraine].

Pagola I, Esteve-Belloch P, Palma JA, Luquin MR, Riverol M, Martinez-Vila E, Irimia P.

Rev Neurol. 2014 Mar 16;58(6):241-6. Spanish.

33.

Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study.

Ortega-Cubero S, Pagola I, Luquin MR, Viteri C, Pastor P, Gállego Pérez-Larraya J, de Castro P, Domínguez I, Irimia P, Martínez-Vila E, Arbizu J, Riverol M.

Neurologia. 2015 Apr;30(3):144-52. doi: 10.1016/j.nrl.2013.12.004. Epub 2014 Feb 26. English, Spanish.

34.

Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.

Secanella-Fandos S, Noguera-Ortega E, Olivares F, Luquin M, Julián E.

J Urol. 2014 May;191(5):1422-8. doi: 10.1016/j.juro.2013.12.002. Epub 2013 Dec 10.

PMID:
24333111
35.

Correction: Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation.

Ordoñez C, Moreno-Murciano P, Hernandez M, Di Caudo C, Mundiñano IC, Vazquez N, Garcia-Verdugo JM, Sanchez-Pernaute R, Luquin MR.

PLoS One. 2013 Sep 20;8(9). doi: 10.1371/annotation/e844adbf-7acf-4b7a-8eaa-46e356c5d9f5. eCollection 2013.

36.

Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.

Riverol M, Ordóñez C, Collantes M, DiCaudo C, Peñuelas I, Arbizu J, Marcilla I, Luquin MR.

Neurobiol Dis. 2014 Feb;62:250-9. doi: 10.1016/j.nbd.2013.09.014. Epub 2013 Sep 27.

PMID:
24076099
37.

Modeling Parkinson's disease in monkeys for translational studies, a critical analysis.

Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM.

Exp Neurol. 2014 Jun;256:133-43. doi: 10.1016/j.expneurol.2013.09.014. Epub 2013 Sep 23. Review.

38.

Advanced Parkinson's disease: clinical characteristics and treatment. Part II.

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Nov-Dec;28(9):558-83. doi: 10.1016/j.nrl.2013.05.002. Epub 2013 Jul 21. Review. English, Spanish.

39.

[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Oct;28(8):503-21. doi: 10.1016/j.nrl.2013.05.001. Epub 2013 Jul 13. Review. Spanish.

40.

Sox-2 Positive Neural Progenitors in the Primate Striatum Undergo Dynamic Changes after Dopamine Denervation.

Ordoñez C, Moreno-Murciano P, Hernandez M, Di Caudo C, Mundiñano IC, Carril-Mundiñano I, Vazquez N, Garcia-Verdugo JM, Sanchez-Pernaute R, Luquin MR.

PLoS One. 2013 Jun 18;8(6):e66377. doi: 10.1371/journal.pone.0066377. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/e844adbf-7acf-4b7a-8eaa-46e356c5d9f5. Carril-Mundiñano, Iñaki [corrected to Mundiñano, Iñaki-Carril].

41.

Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys.

Mundiñano IC, Hernandez M, Dicaudo C, Ordoñez C, Marcilla I, Tuñon MT, Luquin MR.

Acta Neuropathol. 2013 Sep;126(3):411-25. doi: 10.1007/s00401-013-1144-3. Epub 2013 Jun 20.

PMID:
23784261
42.

Is cardiac function impaired in premotor Parkinson's disease? A retrospective cohort study.

Palma JA, Carmona-Abellan MM, Barriobero N, Trevino-Peinado C, Garcia-Lopez M, Fernandez-Jarne E, Luquin MR.

Mov Disord. 2013 May;28(5):591-6. doi: 10.1002/mds.25431. Epub 2013 Mar 11.

PMID:
23483644
43.

Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.

DiCaudo C, Riverol M, Mundiñano IC, Ordoñez C, Hernández M, Marcilla I, Luquin MR.

PLoS One. 2012;7(11):e50842. doi: 10.1371/journal.pone.0050842. Epub 2012 Nov 30.

44.

[Levodopa in the treatment of Parkinson's disease: myths and realties].

Luquin MR, García-Ruiz PJ, Martí MJ, Rojo A, Vela L, Grandas FJ, Bravo-Utrera M, Burguera JA, Chacón JR, Campos-Arillo VM, Durán-Herrera C, Fernández-García JM, García-Ramos R, Gómez-Esteban JC, Gutierrez J, Juni J, Mata M, Martínez-Castrillo JC, Olivares J, Ribacoba-Montero R, Santos-García D, Sierra M, Valero-Merino C.

Rev Neurol. 2012 Dec 1;55(11):669-88. Review. Spanish.

45.

[Limits of conventional oral and transdermal medication in Parkinson's disease].

García-Ruiz PJ, Luquin MR.

Rev Neurol. 2012;55 Suppl 1:S3-6. Review. Spanish.

PMID:
23169231
46.

[Presentation].

García-Ruiz PJ, Luquin MR, Martínez-Castrillo JC.

Rev Neurol. 2012;55 Suppl 1:S1. Spanish. No abstract available.

PMID:
23169226
47.

Connaught and Russian strains showed the highest direct antitumor effects of different Bacillus Calmette-Guérin substrains.

Secanella-Fandos S, Luquin M, Julián E.

J Urol. 2013 Feb;189(2):711-8. doi: 10.1016/j.juro.2012.09.049. Epub 2012 Oct 8.

PMID:
22982433
48.

Cord factors from atypical mycobacteria (Mycobacterium alvei, Mycobacterium brumae) stimulate the secretion of some pro-inflammatory cytokines of relevance in tuberculosis.

Linares C, Bernabéu A, Luquin M, Valero-Guillén PL.

Microbiology. 2012 Nov;158(Pt 11):2878-85. doi: 10.1099/mic.0.060681-0. Epub 2012 Sep 13.

PMID:
22977091
49.

[Clinical experience of treatment with onabotulinumtoxin A in patients with refractory migraine].

Palma JA, Irimia P, Fernandez-Torron R, Ortega-Cubero S, Riverol M, Luquin MR, Martinez-Vila E.

Rev Neurol. 2012 Jun 16;54(12):705-11. Spanish.

50.

Cyclopropanation of α-mycolic acids is not required for cording in Mycobacterium brumae and Mycobacterium fallax.

Brambilla C, Sánchez-Chardi A, Pérez-Trujillo M, Julián E, Luquin M.

Microbiology. 2012 Jun;158(Pt 6):1615-21. doi: 10.1099/mic.0.057919-0. Epub 2012 Apr 5.

PMID:
22493302

Supplemental Content

Loading ...
Support Center